nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Adenosine monophosphate—CREB1—sarcoma	0.0314	0.712	CrCbGaD
Regadenoson—Adenosine monophosphate—SRC—sarcoma	0.0127	0.288	CrCbGaD
Regadenoson—Eye disorder—Etoposide—sarcoma	0.0031	0.00324	CcSEcCtD
Regadenoson—Convulsion—Vincristine—sarcoma	0.00308	0.00323	CcSEcCtD
Regadenoson—Cardiac disorder—Etoposide—sarcoma	0.00307	0.00322	CcSEcCtD
Regadenoson—Flushing—Etoposide—sarcoma	0.00307	0.00322	CcSEcCtD
Regadenoson—Hypertension—Vincristine—sarcoma	0.00307	0.00321	CcSEcCtD
Regadenoson—Myalgia—Vincristine—sarcoma	0.00303	0.00317	CcSEcCtD
Regadenoson—Cough—Mitoxantrone—sarcoma	0.00302	0.00316	CcSEcCtD
Regadenoson—Angiopathy—Etoposide—sarcoma	0.00301	0.00314	CcSEcCtD
Regadenoson—Convulsion—Mitoxantrone—sarcoma	0.003	0.00314	CcSEcCtD
Regadenoson—Hypertension—Mitoxantrone—sarcoma	0.00299	0.00313	CcSEcCtD
Regadenoson—Immune system disorder—Etoposide—sarcoma	0.00299	0.00313	CcSEcCtD
Regadenoson—Mediastinal disorder—Etoposide—sarcoma	0.00299	0.00312	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00298	0.00312	CcSEcCtD
Regadenoson—Eye pain—Epirubicin—sarcoma	0.00297	0.00311	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00296	0.0031	CcSEcCtD
Regadenoson—Chest pain—Mitoxantrone—sarcoma	0.00295	0.00309	CcSEcCtD
Regadenoson—Arthralgia—Mitoxantrone—sarcoma	0.00295	0.00309	CcSEcCtD
Regadenoson—Myalgia—Mitoxantrone—sarcoma	0.00295	0.00309	CcSEcCtD
Regadenoson—Paraesthesia—Thiotepa—sarcoma	0.00294	0.00308	CcSEcCtD
Regadenoson—Anxiety—Mitoxantrone—sarcoma	0.00294	0.00308	CcSEcCtD
Regadenoson—Discomfort—Mitoxantrone—sarcoma	0.00292	0.00305	CcSEcCtD
Regadenoson—Somnolence—Thiotepa—sarcoma	0.00291	0.00305	CcSEcCtD
Regadenoson—Anaphylactic shock—Vincristine—sarcoma	0.0029	0.00304	CcSEcCtD
Regadenoson—Nervous system disorder—Vincristine—sarcoma	0.00285	0.00298	CcSEcCtD
Regadenoson—Anaphylactic shock—Mitoxantrone—sarcoma	0.00283	0.00296	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Thiotepa—sarcoma	0.00283	0.00296	CcSEcCtD
Regadenoson—Dysgeusia—Etoposide—sarcoma	0.00282	0.00295	CcSEcCtD
Regadenoson—Renal impairment—Epirubicin—sarcoma	0.00282	0.00295	CcSEcCtD
Regadenoson—Hyperhidrosis—Vincristine—sarcoma	0.00281	0.00294	CcSEcCtD
Regadenoson—Pain—Thiotepa—sarcoma	0.0028	0.00293	CcSEcCtD
Regadenoson—Shock—Mitoxantrone—sarcoma	0.00278	0.00291	CcSEcCtD
Regadenoson—Pain—Dactinomycin—sarcoma	0.00278	0.00291	CcSEcCtD
Regadenoson—Tachycardia—Mitoxantrone—sarcoma	0.00276	0.00289	CcSEcCtD
Regadenoson—Eye pain—Doxorubicin—sarcoma	0.00275	0.00288	CcSEcCtD
Regadenoson—Skin disorder—Mitoxantrone—sarcoma	0.00275	0.00287	CcSEcCtD
Regadenoson—Cerebrovascular accident—Epirubicin—sarcoma	0.00274	0.00286	CcSEcCtD
Regadenoson—Hyperhidrosis—Mitoxantrone—sarcoma	0.00273	0.00286	CcSEcCtD
Regadenoson—Hypotension—Vincristine—sarcoma	0.00271	0.00284	CcSEcCtD
Regadenoson—Feeling abnormal—Thiotepa—sarcoma	0.0027	0.00282	CcSEcCtD
Regadenoson—Pain in extremity—Epirubicin—sarcoma	0.00268	0.00281	CcSEcCtD
Regadenoson—Feeling abnormal—Dactinomycin—sarcoma	0.00268	0.0028	CcSEcCtD
Regadenoson—Gastrointestinal pain—Thiotepa—sarcoma	0.00268	0.0028	CcSEcCtD
Regadenoson—Ill-defined disorder—Etoposide—sarcoma	0.00268	0.0028	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dactinomycin—sarcoma	0.00266	0.00278	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Vincristine—sarcoma	0.00265	0.00277	CcSEcCtD
Regadenoson—Hypotension—Mitoxantrone—sarcoma	0.00264	0.00277	CcSEcCtD
Regadenoson—Insomnia—Vincristine—sarcoma	0.00263	0.00275	CcSEcCtD
Regadenoson—Renal impairment—Doxorubicin—sarcoma	0.00261	0.00273	CcSEcCtD
Regadenoson—Paraesthesia—Vincristine—sarcoma	0.00261	0.00273	CcSEcCtD
Regadenoson—Urticaria—Thiotepa—sarcoma	0.0026	0.00272	CcSEcCtD
Regadenoson—Malaise—Etoposide—sarcoma	0.0026	0.00272	CcSEcCtD
Regadenoson—Abdominal pain—Thiotepa—sarcoma	0.00259	0.00271	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00258	0.0027	CcSEcCtD
Regadenoson—Abdominal pain—Dactinomycin—sarcoma	0.00257	0.00269	CcSEcCtD
Regadenoson—Cardiac arrest—Epirubicin—sarcoma	0.00255	0.00267	CcSEcCtD
Regadenoson—Paraesthesia—Mitoxantrone—sarcoma	0.00254	0.00266	CcSEcCtD
Regadenoson—Loss of consciousness—Etoposide—sarcoma	0.00253	0.00265	CcSEcCtD
Regadenoson—Cerebrovascular accident—Doxorubicin—sarcoma	0.00253	0.00265	CcSEcCtD
Regadenoson—Dyspnoea—Mitoxantrone—sarcoma	0.00252	0.00264	CcSEcCtD
Regadenoson—Cough—Etoposide—sarcoma	0.00252	0.00263	CcSEcCtD
Regadenoson—Somnolence—Mitoxantrone—sarcoma	0.00251	0.00263	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Vincristine—sarcoma	0.00251	0.00262	CcSEcCtD
Regadenoson—Convulsion—Etoposide—sarcoma	0.0025	0.00261	CcSEcCtD
Regadenoson—Hypertension—Etoposide—sarcoma	0.00249	0.0026	CcSEcCtD
Regadenoson—Pain—Vincristine—sarcoma	0.00248	0.0026	CcSEcCtD
Regadenoson—Pain in extremity—Doxorubicin—sarcoma	0.00248	0.0026	CcSEcCtD
Regadenoson—Chest pain—Etoposide—sarcoma	0.00245	0.00257	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00244	0.00255	CcSEcCtD
Regadenoson—Discomfort—Etoposide—sarcoma	0.00243	0.00254	CcSEcCtD
Regadenoson—Pain—Mitoxantrone—sarcoma	0.00242	0.00253	CcSEcCtD
Regadenoson—Hypersensitivity—Thiotepa—sarcoma	0.00241	0.00252	CcSEcCtD
Regadenoson—Hypersensitivity—Dactinomycin—sarcoma	0.0024	0.00251	CcSEcCtD
Regadenoson—Gastrointestinal pain—Vincristine—sarcoma	0.00238	0.00248	CcSEcCtD
Regadenoson—Cardiac arrest—Doxorubicin—sarcoma	0.00236	0.00247	CcSEcCtD
Regadenoson—Anaphylactic shock—Etoposide—sarcoma	0.00235	0.00246	CcSEcCtD
Regadenoson—Asthenia—Thiotepa—sarcoma	0.00235	0.00246	CcSEcCtD
Regadenoson—Abdominal distension—Epirubicin—sarcoma	0.00234	0.00244	CcSEcCtD
Regadenoson—Asthenia—Dactinomycin—sarcoma	0.00233	0.00244	CcSEcCtD
Regadenoson—Feeling abnormal—Mitoxantrone—sarcoma	0.00233	0.00244	CcSEcCtD
Regadenoson—Asthma—Epirubicin—sarcoma	0.00232	0.00243	CcSEcCtD
Regadenoson—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00231	0.00242	CcSEcCtD
Regadenoson—Tachycardia—Etoposide—sarcoma	0.0023	0.0024	CcSEcCtD
Regadenoson—Abdominal pain—Vincristine—sarcoma	0.0023	0.0024	CcSEcCtD
Regadenoson—Skin disorder—Etoposide—sarcoma	0.00229	0.00239	CcSEcCtD
Regadenoson—Hyperhidrosis—Etoposide—sarcoma	0.00227	0.00238	CcSEcCtD
Regadenoson—Angina pectoris—Epirubicin—sarcoma	0.00226	0.00236	CcSEcCtD
Regadenoson—Urticaria—Mitoxantrone—sarcoma	0.00225	0.00235	CcSEcCtD
Regadenoson—Diarrhoea—Thiotepa—sarcoma	0.00224	0.00234	CcSEcCtD
Regadenoson—Abdominal pain—Mitoxantrone—sarcoma	0.00224	0.00234	CcSEcCtD
Regadenoson—Diarrhoea—Dactinomycin—sarcoma	0.00222	0.00233	CcSEcCtD
Regadenoson—Hypotension—Etoposide—sarcoma	0.0022	0.0023	CcSEcCtD
Regadenoson—Dizziness—Thiotepa—sarcoma	0.00217	0.00227	CcSEcCtD
Regadenoson—Abdominal distension—Doxorubicin—sarcoma	0.00216	0.00226	CcSEcCtD
Regadenoson—Asthma—Doxorubicin—sarcoma	0.00215	0.00225	CcSEcCtD
Regadenoson—Hypersensitivity—Vincristine—sarcoma	0.00214	0.00224	CcSEcCtD
Regadenoson—Paraesthesia—Etoposide—sarcoma	0.00211	0.00221	CcSEcCtD
Regadenoson—Dyspnoea—Etoposide—sarcoma	0.0021	0.00219	CcSEcCtD
Regadenoson—Somnolence—Etoposide—sarcoma	0.00209	0.00219	CcSEcCtD
Regadenoson—Angina pectoris—Doxorubicin—sarcoma	0.00209	0.00219	CcSEcCtD
Regadenoson—Hypersensitivity—Mitoxantrone—sarcoma	0.00208	0.00218	CcSEcCtD
Regadenoson—Asthenia—Vincristine—sarcoma	0.00208	0.00218	CcSEcCtD
Regadenoson—Vomiting—Thiotepa—sarcoma	0.00208	0.00218	CcSEcCtD
Regadenoson—Vomiting—Dactinomycin—sarcoma	0.00207	0.00216	CcSEcCtD
Regadenoson—Rash—Thiotepa—sarcoma	0.00207	0.00216	CcSEcCtD
Regadenoson—Dermatitis—Thiotepa—sarcoma	0.00206	0.00216	CcSEcCtD
Regadenoson—Headache—Thiotepa—sarcoma	0.00205	0.00215	CcSEcCtD
Regadenoson—Rash—Dactinomycin—sarcoma	0.00205	0.00214	CcSEcCtD
Regadenoson—Renal failure—Epirubicin—sarcoma	0.00203	0.00213	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Etoposide—sarcoma	0.00203	0.00213	CcSEcCtD
Regadenoson—Asthenia—Mitoxantrone—sarcoma	0.00203	0.00212	CcSEcCtD
Regadenoson—Pain—Etoposide—sarcoma	0.00201	0.0021	CcSEcCtD
Regadenoson—Diarrhoea—Vincristine—sarcoma	0.00199	0.00208	CcSEcCtD
Regadenoson—Nausea—Thiotepa—sarcoma	0.00195	0.00204	CcSEcCtD
Regadenoson—Feeling abnormal—Etoposide—sarcoma	0.00194	0.00203	CcSEcCtD
Regadenoson—Diarrhoea—Mitoxantrone—sarcoma	0.00194	0.00202	CcSEcCtD
Regadenoson—Nausea—Dactinomycin—sarcoma	0.00193	0.00202	CcSEcCtD
Regadenoson—Gastrointestinal pain—Etoposide—sarcoma	0.00192	0.00201	CcSEcCtD
Regadenoson—Dizziness—Vincristine—sarcoma	0.00192	0.00201	CcSEcCtD
Regadenoson—Bradycardia—Epirubicin—sarcoma	0.00189	0.00198	CcSEcCtD
Regadenoson—Renal failure—Doxorubicin—sarcoma	0.00188	0.00197	CcSEcCtD
Regadenoson—Urticaria—Etoposide—sarcoma	0.00187	0.00196	CcSEcCtD
Regadenoson—Abdominal pain—Etoposide—sarcoma	0.00186	0.00195	CcSEcCtD
Regadenoson—Hypoaesthesia—Epirubicin—sarcoma	0.00185	0.00193	CcSEcCtD
Regadenoson—Vomiting—Vincristine—sarcoma	0.00185	0.00193	CcSEcCtD
Regadenoson—Rash—Vincristine—sarcoma	0.00183	0.00192	CcSEcCtD
Regadenoson—Dermatitis—Vincristine—sarcoma	0.00183	0.00191	CcSEcCtD
Regadenoson—Connective tissue disorder—Epirubicin—sarcoma	0.00182	0.00191	CcSEcCtD
Regadenoson—Headache—Vincristine—sarcoma	0.00182	0.0019	CcSEcCtD
Regadenoson—Vomiting—Mitoxantrone—sarcoma	0.0018	0.00188	CcSEcCtD
Regadenoson—Rash—Mitoxantrone—sarcoma	0.00178	0.00187	CcSEcCtD
Regadenoson—Dermatitis—Mitoxantrone—sarcoma	0.00178	0.00186	CcSEcCtD
Regadenoson—Headache—Mitoxantrone—sarcoma	0.00177	0.00185	CcSEcCtD
Regadenoson—Bradycardia—Doxorubicin—sarcoma	0.00175	0.00183	CcSEcCtD
Regadenoson—Eye disorder—Epirubicin—sarcoma	0.00174	0.00182	CcSEcCtD
Regadenoson—Hypersensitivity—Etoposide—sarcoma	0.00173	0.00181	CcSEcCtD
Regadenoson—Tinnitus—Epirubicin—sarcoma	0.00173	0.00181	CcSEcCtD
Regadenoson—Nausea—Vincristine—sarcoma	0.00173	0.0018	CcSEcCtD
Regadenoson—Flushing—Epirubicin—sarcoma	0.00172	0.0018	CcSEcCtD
Regadenoson—Cardiac disorder—Epirubicin—sarcoma	0.00172	0.0018	CcSEcCtD
Regadenoson—Hypoaesthesia—Doxorubicin—sarcoma	0.00171	0.00179	CcSEcCtD
Regadenoson—Asthenia—Etoposide—sarcoma	0.00169	0.00177	CcSEcCtD
Regadenoson—Connective tissue disorder—Doxorubicin—sarcoma	0.00169	0.00177	CcSEcCtD
Regadenoson—Angiopathy—Epirubicin—sarcoma	0.00168	0.00176	CcSEcCtD
Regadenoson—Nausea—Mitoxantrone—sarcoma	0.00168	0.00176	CcSEcCtD
Regadenoson—Immune system disorder—Epirubicin—sarcoma	0.00168	0.00175	CcSEcCtD
Regadenoson—Mediastinal disorder—Epirubicin—sarcoma	0.00167	0.00175	CcSEcCtD
Regadenoson—Mental disorder—Epirubicin—sarcoma	0.00163	0.0017	CcSEcCtD
Regadenoson—Erythema—Epirubicin—sarcoma	0.00162	0.00169	CcSEcCtD
Regadenoson—Diarrhoea—Etoposide—sarcoma	0.00161	0.00168	CcSEcCtD
Regadenoson—Eye disorder—Doxorubicin—sarcoma	0.00161	0.00168	CcSEcCtD
Regadenoson—Tinnitus—Doxorubicin—sarcoma	0.0016	0.00168	CcSEcCtD
Regadenoson—Cardiac disorder—Doxorubicin—sarcoma	0.00159	0.00167	CcSEcCtD
Regadenoson—Flushing—Doxorubicin—sarcoma	0.00159	0.00167	CcSEcCtD
Regadenoson—Dysgeusia—Epirubicin—sarcoma	0.00158	0.00166	CcSEcCtD
Regadenoson—Angiopathy—Doxorubicin—sarcoma	0.00156	0.00163	CcSEcCtD
Regadenoson—Dizziness—Etoposide—sarcoma	0.00156	0.00163	CcSEcCtD
Regadenoson—Immune system disorder—Doxorubicin—sarcoma	0.00155	0.00162	CcSEcCtD
Regadenoson—Mediastinal disorder—Doxorubicin—sarcoma	0.00155	0.00162	CcSEcCtD
Regadenoson—Vision blurred—Epirubicin—sarcoma	0.00152	0.00159	CcSEcCtD
Regadenoson—Mental disorder—Doxorubicin—sarcoma	0.00151	0.00157	CcSEcCtD
Regadenoson—Ill-defined disorder—Epirubicin—sarcoma	0.0015	0.00157	CcSEcCtD
Regadenoson—Vomiting—Etoposide—sarcoma	0.0015	0.00157	CcSEcCtD
Regadenoson—Erythema—Doxorubicin—sarcoma	0.0015	0.00156	CcSEcCtD
Regadenoson—Rash—Etoposide—sarcoma	0.00148	0.00155	CcSEcCtD
Regadenoson—Dermatitis—Etoposide—sarcoma	0.00148	0.00155	CcSEcCtD
Regadenoson—Headache—Etoposide—sarcoma	0.00147	0.00154	CcSEcCtD
Regadenoson—Dysgeusia—Doxorubicin—sarcoma	0.00146	0.00153	CcSEcCtD
Regadenoson—Malaise—Epirubicin—sarcoma	0.00146	0.00152	CcSEcCtD
Regadenoson—Syncope—Epirubicin—sarcoma	0.00145	0.00152	CcSEcCtD
Regadenoson—Palpitations—Epirubicin—sarcoma	0.00143	0.00149	CcSEcCtD
Regadenoson—Loss of consciousness—Epirubicin—sarcoma	0.00142	0.00149	CcSEcCtD
Regadenoson—Cough—Epirubicin—sarcoma	0.00141	0.00148	CcSEcCtD
Regadenoson—Vision blurred—Doxorubicin—sarcoma	0.00141	0.00147	CcSEcCtD
Regadenoson—Convulsion—Epirubicin—sarcoma	0.0014	0.00146	CcSEcCtD
Regadenoson—Nausea—Etoposide—sarcoma	0.0014	0.00146	CcSEcCtD
Regadenoson—Hypertension—Epirubicin—sarcoma	0.0014	0.00146	CcSEcCtD
Regadenoson—Ill-defined disorder—Doxorubicin—sarcoma	0.00139	0.00145	CcSEcCtD
Regadenoson—Myalgia—Epirubicin—sarcoma	0.00138	0.00144	CcSEcCtD
Regadenoson—Arthralgia—Epirubicin—sarcoma	0.00138	0.00144	CcSEcCtD
Regadenoson—Chest pain—Epirubicin—sarcoma	0.00138	0.00144	CcSEcCtD
Regadenoson—Anxiety—Epirubicin—sarcoma	0.00137	0.00143	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00137	0.00143	CcSEcCtD
Regadenoson—Discomfort—Epirubicin—sarcoma	0.00136	0.00142	CcSEcCtD
Regadenoson—Malaise—Doxorubicin—sarcoma	0.00135	0.00141	CcSEcCtD
Regadenoson—Syncope—Doxorubicin—sarcoma	0.00134	0.0014	CcSEcCtD
Regadenoson—Palpitations—Doxorubicin—sarcoma	0.00132	0.00138	CcSEcCtD
Regadenoson—Anaphylactic shock—Epirubicin—sarcoma	0.00132	0.00138	CcSEcCtD
Regadenoson—Loss of consciousness—Doxorubicin—sarcoma	0.00131	0.00137	CcSEcCtD
Regadenoson—Cough—Doxorubicin—sarcoma	0.0013	0.00137	CcSEcCtD
Regadenoson—Shock—Epirubicin—sarcoma	0.0013	0.00136	CcSEcCtD
Regadenoson—Convulsion—Doxorubicin—sarcoma	0.0013	0.00136	CcSEcCtD
Regadenoson—Nervous system disorder—Epirubicin—sarcoma	0.00129	0.00135	CcSEcCtD
Regadenoson—Hypertension—Doxorubicin—sarcoma	0.00129	0.00135	CcSEcCtD
Regadenoson—Tachycardia—Epirubicin—sarcoma	0.00129	0.00135	CcSEcCtD
Regadenoson—Skin disorder—Epirubicin—sarcoma	0.00128	0.00134	CcSEcCtD
Regadenoson—Hyperhidrosis—Epirubicin—sarcoma	0.00128	0.00133	CcSEcCtD
Regadenoson—Myalgia—Doxorubicin—sarcoma	0.00127	0.00133	CcSEcCtD
Regadenoson—Arthralgia—Doxorubicin—sarcoma	0.00127	0.00133	CcSEcCtD
Regadenoson—Chest pain—Doxorubicin—sarcoma	0.00127	0.00133	CcSEcCtD
Regadenoson—Anxiety—Doxorubicin—sarcoma	0.00127	0.00133	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00126	0.00132	CcSEcCtD
Regadenoson—Discomfort—Doxorubicin—sarcoma	0.00126	0.00132	CcSEcCtD
Regadenoson—Hypotension—Epirubicin—sarcoma	0.00123	0.00129	CcSEcCtD
Regadenoson—Anaphylactic shock—Doxorubicin—sarcoma	0.00122	0.00128	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Epirubicin—sarcoma	0.0012	0.00126	CcSEcCtD
Regadenoson—Shock—Doxorubicin—sarcoma	0.0012	0.00126	CcSEcCtD
Regadenoson—Nervous system disorder—Doxorubicin—sarcoma	0.0012	0.00125	CcSEcCtD
Regadenoson—Insomnia—Epirubicin—sarcoma	0.00119	0.00125	CcSEcCtD
Regadenoson—Tachycardia—Doxorubicin—sarcoma	0.00119	0.00125	CcSEcCtD
Regadenoson—Skin disorder—Doxorubicin—sarcoma	0.00119	0.00124	CcSEcCtD
Regadenoson—Paraesthesia—Epirubicin—sarcoma	0.00118	0.00124	CcSEcCtD
Regadenoson—Hyperhidrosis—Doxorubicin—sarcoma	0.00118	0.00123	CcSEcCtD
Regadenoson—Dyspnoea—Epirubicin—sarcoma	0.00118	0.00123	CcSEcCtD
Regadenoson—Somnolence—Epirubicin—sarcoma	0.00117	0.00123	CcSEcCtD
Regadenoson—Hypotension—Doxorubicin—sarcoma	0.00114	0.00119	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Epirubicin—sarcoma	0.00114	0.00119	CcSEcCtD
Regadenoson—Pain—Epirubicin—sarcoma	0.00113	0.00118	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00111	0.00116	CcSEcCtD
Regadenoson—Insomnia—Doxorubicin—sarcoma	0.0011	0.00115	CcSEcCtD
Regadenoson—Paraesthesia—Doxorubicin—sarcoma	0.0011	0.00115	CcSEcCtD
Regadenoson—Dyspnoea—Doxorubicin—sarcoma	0.00109	0.00114	CcSEcCtD
Regadenoson—Feeling abnormal—Epirubicin—sarcoma	0.00109	0.00114	CcSEcCtD
Regadenoson—Somnolence—Doxorubicin—sarcoma	0.00109	0.00114	CcSEcCtD
Regadenoson—Gastrointestinal pain—Epirubicin—sarcoma	0.00108	0.00113	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00105	0.0011	CcSEcCtD
Regadenoson—Urticaria—Epirubicin—sarcoma	0.00105	0.0011	CcSEcCtD
Regadenoson—Pain—Doxorubicin—sarcoma	0.00104	0.00109	CcSEcCtD
Regadenoson—Abdominal pain—Epirubicin—sarcoma	0.00104	0.00109	CcSEcCtD
Regadenoson—Feeling abnormal—Doxorubicin—sarcoma	0.00101	0.00105	CcSEcCtD
Regadenoson—Gastrointestinal pain—Doxorubicin—sarcoma	0.000998	0.00104	CcSEcCtD
Regadenoson—Hypersensitivity—Epirubicin—sarcoma	0.000972	0.00102	CcSEcCtD
Regadenoson—Urticaria—Doxorubicin—sarcoma	0.00097	0.00101	CcSEcCtD
Regadenoson—Abdominal pain—Doxorubicin—sarcoma	0.000965	0.00101	CcSEcCtD
Regadenoson—Asthenia—Epirubicin—sarcoma	0.000946	0.00099	CcSEcCtD
Regadenoson—Diarrhoea—Epirubicin—sarcoma	0.000902	0.000944	CcSEcCtD
Regadenoson—Hypersensitivity—Doxorubicin—sarcoma	0.000899	0.000941	CcSEcCtD
Regadenoson—Asthenia—Doxorubicin—sarcoma	0.000876	0.000916	CcSEcCtD
Regadenoson—Dizziness—Epirubicin—sarcoma	0.000872	0.000912	CcSEcCtD
Regadenoson—Vomiting—Epirubicin—sarcoma	0.000839	0.000877	CcSEcCtD
Regadenoson—Diarrhoea—Doxorubicin—sarcoma	0.000835	0.000874	CcSEcCtD
Regadenoson—Rash—Epirubicin—sarcoma	0.000832	0.00087	CcSEcCtD
Regadenoson—Dermatitis—Epirubicin—sarcoma	0.000831	0.000869	CcSEcCtD
Regadenoson—Headache—Epirubicin—sarcoma	0.000826	0.000864	CcSEcCtD
Regadenoson—Dizziness—Doxorubicin—sarcoma	0.000807	0.000844	CcSEcCtD
Regadenoson—Nausea—Epirubicin—sarcoma	0.000783	0.00082	CcSEcCtD
Regadenoson—Vomiting—Doxorubicin—sarcoma	0.000776	0.000812	CcSEcCtD
Regadenoson—Rash—Doxorubicin—sarcoma	0.00077	0.000805	CcSEcCtD
Regadenoson—Dermatitis—Doxorubicin—sarcoma	0.000769	0.000804	CcSEcCtD
Regadenoson—Headache—Doxorubicin—sarcoma	0.000765	0.0008	CcSEcCtD
Regadenoson—Nausea—Doxorubicin—sarcoma	0.000725	0.000758	CcSEcCtD
